US FDA Approval Of Novo Nordisk's Victoza For Young T2D Patients A Treatment Milestone

 
• By Sten Stovall
Blood sample
Move Gives Young T2D patients First New Treatment Option In Nearly 20 Years • Source: Shutterstock

More from New Products

More from Scrip